Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicxi
Biotech
Ottimo raises $140M to ready PD1/VEGFR2 antibody for clinic
Two months after former Seagen CEO David Epstein unveiled his new project, the biotech has secured $140 million in series A funds.
James Waldron
Dec 19, 2024 6:58am
Former Seagen CEO unveils new startup Ottimo Pharma
Oct 28, 2024 11:24am
'Next wave of IPOs' will arrive in summer, predicts VC partner
May 3, 2024 10:49am
Medicxi merges 6 dermatology biotechs into one, adds $100M
Feb 11, 2024 7:00pm
Why investors are staying loyal to European biotech in 2023
Oct 2, 2023 3:00am
Medicxi rakes in $400M for 4th life sciences fund
Jul 27, 2023 3:00am
